Skip to main content
Clinical Trials/NCT02708524
NCT02708524
Completed
Not Applicable

Clinical Study of Approved and Investigational Contact Lenses

Johnson & Johnson Vision Care, Inc.0 sites554 target enrollmentJanuary 2016
ConditionsVisual Acuity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Visual Acuity
Sponsor
Johnson & Johnson Vision Care, Inc.
Enrollment
554
Primary Endpoint
Frequency of Lens Awareness Individual Item
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This is a multi-site, 5-visit, double-masked, dispensing study comparing an investigational contact lens with currently-marketed contact lenses. The objective of the study is to evaluate the comfort of the lenses when worn for 30 (-2/+6) days on daily wear modality.

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
March 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
  • The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • The subject must be between 18 to 40 years of age at the time of consent.
  • The subject's spherical equivalent distance refraction must be in the range of -1.25 to -6.00 in each eye.
  • The subject's refractive cylinder must be ≤1.00D in each eye.
  • The subject must have best corrected visual acuity of 20/30 or better in each eye.
  • The subject must be a habitual frequent replacement (reusable) daily wear spherical silicone hydrogel soft contact lens wearer in both eyes.
  • The subject must be able to wear contact lenses for a minimum of 8 hours, 4 days per week.
  • The subject must have normal eyes (i.e., no ocular medications or infections of any type).

Exclusion Criteria

  • Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).
  • Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
  • Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear.
  • Any known sensitive/allergic to Ingredients of OPTI-FREE® PureMoist® solution.
  • Any daily disposable, extended wear, monovision, toric or multi-focal contact lens correction.
  • Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or moderate or above corneal distortion.
  • Any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), etc.)
  • Any grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear.
  • Any ocular infection.
  • Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.

Outcomes

Primary Outcomes

Frequency of Lens Awareness Individual Item

Time Frame: 1 month Follow-up

Frequency of Lens Awareness was assessed using a questionnaire item at Baseline, 1-week, 2-week, 3-week and 4-week follow-up. Reposes are scaled as (Always, Frequently, Occasionally, Rarely, Never or Don't Know). Only the number of participants that reported Rarely or Never (Top-Two-Box) was reported here.

Subjective Overall Comfort Composite Score

Time Frame: Up to 1 month Follow-up

Subjective Overall Comfort was evaluated using the Contact Lens User Experience Comfort scores (CLUE). CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response.Range is 0 to 120. CLUE was collect at Baseline, Post Lens Fit 1-, 2-, 3- and 4- week follow-ups.

Overall Comfort Individual Item

Time Frame: 1 month follow-up

Overall Comfort was assessed using a questionnaire item at Baseline, 1-week, 2-week, 3-week and 4-week follow-up. Responses are on a 5 likert scale (Excellent, Very Good, Good, Fair and Poor). Only the percentage of participants that reported Excellent or Very good (Top-Two-Box) was reported here.

Comfort at the End of the Day Individual Item

Time Frame: 1 month Follow-up

Comfort at the End of the Day was assessed using a questionnaire item at Baseline, 1-week, 2-week, 3-week and 4-week follow-up. Reposes are on a 5 like-rt scale (Excellent, Very Good, Good, Fair and Poor). Only the percentage of participants that reported Excellent or Very good (Top-Two-Box) was reported here.

Comfort Each and Everyday Individual Item

Time Frame: 1 month Follow-up

Comfort each and everyday was assessed using a questionnaire item at Baseline, 1-week, 2-week, 3-week and 4-week follow-up. Reposes are on a 5 likert scale (Excellent, Very Good, Good, Fair and Poor). Only the percentage of participants that reported Excellent or Very good (Top-Two-Box) was reported here.

Frequency of Experiencing Dryness Individual Item

Time Frame: 1 month Follow-up

Frequency of Experiencing Dryness was assessed using a questionnaire item at Baseline, 1-week, 2-week, 3-week and 4-week follow-up. Reposes are scaled as (Always, Frequently, Occasionally, Rarely, Never or Don't Know). Only the number of participants that reported Rarely or Never (Top-Two-Box) was reported here.

Making Your Eyes Feel Moist Throughout the Day Individual Item

Time Frame: Up to 1 month Follow-up

Making your eyes feel moist throughout the day was assessed using a questionnaire item at Baseline, 1-week, 2-week, 3-week and 4-week follow-up. Reposes are on a 5 likert scale (Excellent, Very Good, Good, Fair and Poor). Only the percentage of participants that reported Excellent or Very good (Top-Two-Box) was reported here.

Secondary Outcomes

  • Overall Opinion Individual Item(Up to 1 month Follow-up)
  • Subjective Overall Quality of Vision Composite Score(Up to 1 month Follow-up)
  • Overall Quality of Vision Individual Item(Up to 1 month Follow-up)

Similar Trials